Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels

Clinical and Experimental Rheumatology

Volumn 21, Issue 4, 2003, Pages 437-444

  Liou, Lieh Bang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

C reactive protein; In vitro cytokines; Monocytes; Untreated rheumatoid arthritis and untreated lupus

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD ANALYSIS; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME POLYMORPHISM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMMUNOSTIMULATION; IN VITRO STUDY; LIVER; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REACTION ANALYSIS; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; SUPERNATANT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; LINEAR MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MONOCYTES; PROBABILITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0042198897     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. WALSH L, DAVIS P, McCONKEY B: Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis. Ann Rheum Dis 1979; 38: 362-3.
2. HONIG S, GOREVIC P, WEISSMANN G: C-reactive protein in systemic lupus erythematosus. Arthritis Rheum 1977; 20: 1065-70.
3. ter BORG E J, HORST G, LIMBRUG PC, VAN RIJSWIJK MH, KALLENBERG CGM: C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: A prospective longitudinal study. J Rheumatol 1990; 17: 1642-8.
4. LIOU LB: Serum and in vitro production of IL-1 receptor antagonist correlate with c-reactive protein levels in newly diagnosed, untreated lupus patients. Clin Exp Rheumatol 2001; 19: 515-23.
5. AKIRA S, HIRANO T, TAGA T, KISHIMOTO T: Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 1990; 4: 2860-7.
6. WANIDWORANUN C, STROBER W: Predominant role of tumor necrosis factor-α in human monocyte IL- 10 synthesis. J Immunol 1993; 151: 6853-61.
7. AREND WP, WELGUS HS, THOMPSON, RC, EISENBERG SP: Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist. J Clin Invest 1990; 85: 1694-7.
8. BAUMAN H, GAULDIE J: The acute phase response. Immunol Today 1994; 2: 74-80.
9. BAUMANN H, GAULDIE J: Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990; 7: 147-59.
10. DEVLIN J, GOUGH A, HUISSOON A et al.: The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. J Rheumatol 1997; 24: 9-13.
11. LACKI JK, SAMBORSKI W. MACKIEWICZ SH: Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins. Clin Rheumatol 1997; 16: 275-8.
12. WAAGE A, SLUPPHAUG G, SHALABY R: Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells and fibroblasts. Eur J Immunol 1990; 20: 2439-43.
13. KOVALOVSKY D, PAE PEREDA M, SAUER J et al.: The Th1 and Th2 cytokines IFN-gamma and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: involvement of IL-1. Eur J Immunol 1998; 28: 2075-85.
14. DINARELLO CA, THOMPSON RC: Blocking IL-1: Effects of IL-1 receptor antagonist in vitro and in vivo. Immunol Today 1991; 121: 404-9.
15. RIVERO M, SANTIAGO B, GALINDO M, BREHMER MT, PABLOS JL: Cyclooxygenase-2 inhibibition lacks immunomodulatory effects on T cells. Clin Exp Rheumatol 2002; 20: 379-85.
16. GABAY C, GENIN B, MENTHA G et al.: IL-1 receptor antagonist (IL-1ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary heapotocytes. Differential regulation in normal and tumour cells. Clin Exp Immunol 1995; 100: 306-13.
17. LOZA E, TINTURE T, SANCHEZ-IBARROLA A: CD5 and CD23 expression on B cells in peripheral blood and synovial fluid of rheumatoid arthritis patients: Relationship with interleukin-4, soluble CD23 and rumour necrosis factor alpha levels. Rheumatology 1999; 38: 325-8.
18. VAZQUEZ-Del MERCADO M, DELGADO-RIZO V, MUNOZ-VALLE JF, OROZCO-ALCALA J, VOLK H-D, ARMENDARIZ-BORUNDA J: Expression of interleukin-1β, tumor necrosis factor α, interleukin-6, -10, and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients. Clin Exp Rheumatol 1999; 17:575-83.
19. AL-AWADHI A, OLUSI S, AL-ZAID N, PRABHA K: Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis. J Rheumatol 1999; 26: 1250-6.
20. CHROMARAT P, BANCHEREAU J, MIOSSEC P: Differential effects of interleukin 10 and 4 on the production of interleukin 6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 1995; 38: 1046-54.
21. WOLFE F: Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997; 24: 1477-85.
22. FOEY AD, FELDMAAN M, BRENNAN FM: Route of monocyte differentiation determines their cytokine production profile: CD4-ligation induces interleukin 10 expression. Cytokine 2000; 12: 1496-505.
23. SHIMAUCHI H, OGAWA T, OKUDA K, KUSSUMOTO Y, OKAADA H: Autoregulatory effect of interleukin 10 on proinflammatory cytokine production by Porphyromonas gingivalis lipopolysaccharide-tolerant human monocytes. Infection Immunity 1999: 67: 2153-9.
24. SPRONK PE, Ter BORG EJ, LIMBERUG PC, KALLENBERG CGM: Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity. Clin Exp Immunol 1992; 90:106-10.